April 29th 2025
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Scalable Membrane Ion-Exchange Chromatography Purification of an Antisense Oligonucleotide
May 2nd 2005Rising drug costs have increased public pressure on the biopharmaceutical industry to find ways to identify and eliminate high-cost unit operations. Biopharmaceutical manufacturing groups now routinely evaluate both productivity as well as economic feasibility for every process step.
New Vaccine Technologies Carry and Deliver by Kaylynn Chiarello
May 2nd 2005Vaccine developers are using novel drug delivery methods that offer advantages over traditional techniques such as improved immunogenicity, better stability, specific control over antigen release, and a wider pool of targeted diseases.
Sieve Use in the Pharmaceutical Industry
May 1st 2005Asieve or screener is an essential part of every pharmaceutical production process, particularly as product quality and integrity are so important. The use of a sieve gets rid of oversized contamination to ensure that ingredients and finished products are quality assured during production and before use or despatch.
Removal of Particles by Ultrafiltration Systems
May 1st 2005Pure water is a raw material of particular importance to the pharmaceutical industry. Drinking water is the basis for the treatment of water for pharmaceutical applications; it is the starting point for the production of the various pharmaceutical water qualities, such as purified water, highly purified water and water for injection.
Transforming Development Productivity Using Integrated Automation
May 1st 2005The FDA initiative —Process Analytical Technologies (PAT) — is slowly gaining momentum, creating a revolution in manufacturing and testing processes that aims to ensure product quality. Its growth will encourage faster testing techniques to bring analytical testing closer to on- and at-line testing during the product manufacturing process.
Glass Reactor Vessel — Value Sealing Innovation
May 1st 2005Active pharmaceutical ingredients (APIs) have become more potent, therefore the requirements of good manufacturing practice (GMP) are making ever more stringent demands on valve design and sealing. An absence of dead space, ease of cleaning and flushing is the norm for valves where cross contamination must be avoided at all costs. Sealing valves to glass reaction vessels has lagged behind valve sealing for steel vessels.